Count | |
| 2 | |
| 3 | |
| 1 | |
| 4 | |
| 1 | |
| 1 | |
Nifedipine/*analogs & derivatives/metabolism/pharmacokinetics | 1 |
| 1 | |
| 4 | |
| 14 | |
| 1 | |
| 1 | |
| 1 | |
| 40 | |
| 6 | |
| 13 | |
| 17 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 6 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Nifedipine/administration & dosage/adverse effects/*therapeutic use | 2 |
Nifedipine/administration & dosage/*analogs & derivatives/pharmacology | 1 |
Nifedipine/adverse effects/*analogs & derivatives/therapeutic use | 1 |
Nifedipine/administration & dosage/adverse effects/therapeutic use | 1 |
| 36 | |
| 1 | |
| 43 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 5 | |
| 4 | |
| 17 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 2 | |
| 2 | |
| 2 | |
| 1 | |
| 2 | |
| 2 | |
| 1 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 5 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 7 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 2 | |
| 3 | |
| 1 | |